blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3368529

EP3368529 - HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.02.2023
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  04.03.2022
FormerGrant of patent is intended
Status updated on  10.11.2021
FormerExamination is in progress
Status updated on  11.02.2021
FormerRequest for examination was made
Status updated on  03.08.2018
FormerThe international publication has been made
Status updated on  05.05.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2018/36]
Inventor(s)01 / FRATTINI, Sara
Boehringer Ingelheim GmbH
Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein / DE
02 / BAKKER, Remko
Boehringer Ingelheim GmbH
Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein / DE
03 / GIOVANNINI, Riccardo
Boehringer Ingelheim GmbH
Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein / DE
04 / HAMPRECHT, Dieter
Boehringer Ingelheim GmbH
Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein / DE
05 / LINGARD, Iain
Boehringer Ingelheim GmbH
Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein / DE
06 / PAUTSCH, Alexander
Boehringer Ingelheim GmbH
Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein / DE
07 / WELLENZOHN, Bernd
Boehringer Ingelheim GmbH
Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein / DE
 [2018/36]
Representative(s)Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2018/36]
Application number, filing date16784206.120.10.2016
[2018/36]
WO2016EP75221
Priority number, dateEP2015019175727.10.2015         Original published format: EP 15191757
[2018/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017072020
Date:04.05.2017
Language:EN
[2017/18]
Type: A1 Application with search report 
No.:EP3368529
Date:05.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 04.05.2017 takes the place of the publication of the European patent application.
[2018/36]
Type: B1 Patent specification 
No.:EP3368529
Date:06.04.2022
Language:EN
[2022/14]
Search report(s)International search report - published on:EP04.05.2017
ClassificationIPC:C07D403/12, A61K31/4155, A61K31/4192, A61P5/48, A61P27/00
[2018/36]
CPC:
C07D401/14 (EP,US); A61K31/438 (EP,US); A61K31/444 (EP,US);
A61K31/4709 (EP,US); A61K45/06 (US); A61P27/00 (EP);
A61P27/02 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P5/48 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D403/12 (EP,US); C07D413/14 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/36]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:HETEROARYLCARBOXAMIDDERIVATE ALS PLASMA-KALLIKREIN-INHIBITOREN[2018/36]
English:HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS[2018/36]
French:UTILISATION DE DÉRIVÉS HÉTÉROARYLCARBOXAMIDES COMME INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE[2018/36]
Entry into regional phase28.05.2018National basic fee paid 
28.05.2018Designation fee(s) paid 
28.05.2018Examination fee paid 
Examination procedure16.03.2018Date on which the examining division has become responsible
28.05.2018Examination requested  [2018/36]
05.12.2018Amendment by applicant (claims and/or description)
10.02.2021Despatch of a communication from the examining division (Time limit: M04)
11.06.2021Reply to a communication from the examining division
11.11.2021Communication of intention to grant the patent
25.02.2022Fee for grant paid
25.02.2022Fee for publishing/printing paid
25.02.2022Receipt of the translation of the claim(s)
Opposition(s)10.01.2023No opposition filed within time limit [2023/11]
Fees paidRenewal fee
31.10.2018Renewal fee patent year 03
31.10.2019Renewal fee patent year 04
02.11.2020Renewal fee patent year 05
02.11.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.10.2016
AL06.04.2022
AT06.04.2022
CY06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
IT06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
MK06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
TR06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
IE20.10.2022
LU20.10.2022
BE31.10.2022
CH31.10.2022
LI31.10.2022
[2024/29]
Former [2024/27]HU20.10.2016
AL06.04.2022
AT06.04.2022
CY06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
IT06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
MK06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
IE20.10.2022
LU20.10.2022
BE31.10.2022
CH31.10.2022
LI31.10.2022
Former [2024/21]HU20.10.2016
AL06.04.2022
AT06.04.2022
CY06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
IT06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
IE20.10.2022
LU20.10.2022
BE31.10.2022
CH31.10.2022
LI31.10.2022
Former [2024/18]HU20.10.2016
AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
IT06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
IE20.10.2022
LU20.10.2022
BE31.10.2022
CH31.10.2022
LI31.10.2022
Former [2024/11]AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
IT06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
IE20.10.2022
LU20.10.2022
BE31.10.2022
CH31.10.2022
LI31.10.2022
Former [2023/48]AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
IE20.10.2022
LU20.10.2022
BE31.10.2022
CH31.10.2022
LI31.10.2022
Former [2023/42]AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
LU20.10.2022
BE31.10.2022
CH31.10.2022
LI31.10.2022
Former [2023/35]AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
LU20.10.2022
CH31.10.2022
LI31.10.2022
Former [2023/30]AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
LU20.10.2022
Former [2023/25]AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
MC06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SI06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
Former [2023/17]AL06.04.2022
AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
Former [2023/09]AT06.04.2022
CZ06.04.2022
DK06.04.2022
EE06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
NL06.04.2022
PL06.04.2022
RO06.04.2022
RS06.04.2022
SE06.04.2022
SK06.04.2022
SM06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
Former [2023/07]AT06.04.2022
DK06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
NL06.04.2022
PL06.04.2022
RS06.04.2022
SE06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
Former [2022/51]AT06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
NL06.04.2022
PL06.04.2022
RS06.04.2022
SE06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
IS06.08.2022
PT08.08.2022
Former [2022/50]AT06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
NL06.04.2022
PL06.04.2022
RS06.04.2022
SE06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
PT08.08.2022
Former [2022/49]AT06.04.2022
ES06.04.2022
FI06.04.2022
HR06.04.2022
LT06.04.2022
LV06.04.2022
NL06.04.2022
SE06.04.2022
BG06.07.2022
NO06.07.2022
GR07.07.2022
PT08.08.2022
Former [2022/47]AT06.04.2022
ES06.04.2022
FI06.04.2022
LT06.04.2022
NL06.04.2022
SE06.04.2022
NO06.07.2022
PT08.08.2022
Former [2022/44]NL06.04.2022
Cited inInternational search[A]WO2009097141  (JOSLIN DIABETES CT [US], et al) [A] 1* claim - *;
 [AD]WO2013111108  (NOVARTIS AG [CH]) [AD] 1 * example -; claim - *;
 [AD]WO2013111107  (NOVARTIS AG [CH]) [AD] 1 * example -; claim - *
by applicantEP2098513
 WO2013111108
 WO2013111107
 WO2014188211
    - NOYORI, J. AM. CHEM. SOC., (1995), vol. 117, no. 28, pages 7562 - 7563
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.